Advertisement

More articles from Research Articles

  • HER2-mediated internalization of cytotoxic agents in ERBB2 amplified or mutant lung cancers
    Bob T. Li, Flavia Michelini, Sandra Misale, Emiliano Cocco, Laura Baldino, Yanyan Cai, Sophie Shifman, Hai-Yan Tu, Mackenzie L Myers, Chongrui Xu, Marissa Mattar, Inna Khodos, Megan Little, Besnik Qeriqi, Gregory Weitsman, Clare J. Wilhelm, Alshad S. Lalani, Irmina Diala, Rachel A. Freedman, Nancy U Lin, David B. Solit, Michael F. Berger, Paul R Barber, Tony Ng, Michael Offin, James M Isbell, David R. Jones, Helena A Yu, Sheeno Thyparambil, Wei-Li Liao, Anuja Bhalkikar, Fabiola Cecchi, David M Hyman, Jason S Lewis, Darren J. Buonocore, Alan L. Ho, Vicky Makker, Jorge S. Reis-Filho, Pedram Razavi, Maria E. Arcila, Mark G. Kris, John T. Poirier, Ronglai Shen, Junji Tsurutani, Gary A Ulaner, Elisa de Stanchina, Neal Rosen, Charles M. Rudin, Maurizio Scaltriti
    Cancer Discovery Jan 2020, CD-20-0215; DOI: 10.1158/2159-8290.CD-20-0215
  • Targeting HER2 with Trastuzumab Deruxtecan: A Dose-Expansion, Phase I Study in Multiple Advanced Solid Tumors
    Junji Tsurutani, Hiroji Iwata, Ian Krop, Pasi A. Jänne, Toshihiko Doi, Shunji Takahashi, Haeseong Park, Charles Redfern, Kenji Tamura, Trisha M. Wise-Draper, Kaku Saito, Masahiro Sugihara, Jasmeet Singh, Takahiro Jikoh, Gilles Gallant, Bob T. Li
    Cancer Discovery Mar 2020, DOI: 10.1158/2159-8290.CD-19-1014
  • Repression of the Type I Interferon pathway underlies MYC & KRAS-dependent evasion of NK & B cells in Pancreatic Ductal Adenocarcinoma
    Nathiya Muthalagu, Tiziana Monteverde, Ximena Raffo-Iraolagoitia, Robert Wiesheu, Declan Whyte, Ann Hedley, Sarah Laing, Bjorn Kruspig, Rosanna Upstill-Goddard, Robin Shaw, Sarah Neidler, Curtis Rink, Saadia A Karim, Katarina Gyuraszova, Colin Nixon, William Clark, Andrew V. Biankin, Leo M Carlin, Seth B Coffelt, Owen J. Sansom, Jennifer P. Morton, Daniel J. Murphy
    Cancer Discovery Jan 2020, CD-19-0620; DOI: 10.1158/2159-8290.CD-19-0620
  • Golgi Acidification by NHE7 Regulates Cytosolic pH Homeostasis in Pancreatic Cancer Cells
    Koen M.O. Galenkamp, Paulina Sosicka, Michael Jung, M. Victoria Recouvreux, Yijuan Zhang, Matthew R. Moldenhauer, Giovanni Brandi, Hudson H. Freeze, Cosimo Commisso
    Cancer Discovery Jan 2020, CD-19-1007; DOI: 10.1158/2159-8290.CD-19-1007
  • Tuning the Antigen Density Requirement for CAR T Cell Activity
    Robbie G. Majzner, Skyler P. Rietberg, Elena Sotillo, Rui Dong, Vipul T. Vachharajani, Louai Labanieh, June H Myklebust, Meena Kadapakkam, Evan W. Weber, Aidan M Tousley, Rebecca M Richards, Sabine Heitzeneder, Sang M Nguyen, Volker Wiebking, Johanna Theruvath, Rachel C Lynn, Peng Xu, Alexander R Dunn, Ronald D Vale, Crystal L. Mackall
    Cancer Discovery Jan 2020, CD-19-0945; DOI: 10.1158/2159-8290.CD-19-0945
  • The Evolutionary Origins of Recurrent Pancreatic Cancer
    Hitomi Sakamoto, Marc A Attiyeh, Jeffrey M Gerold, Alvin P Makohon-Moore, Akimasa Hayashi, Jungeui Hong, Rajya Kappagantula, Lance Zhang, Jerry P Melchor, Johannes G Reiter, Alexander Heyde, Craig M. Bielski, Alexander V Penson, Mithat Gonen, Debyani Chakravarty, Eileen M O'Reilly, Laura D. Wood, Ralph H. Hruban, Martin A. Nowak, Nicholas D. Socci, Barry S. Taylor, Christine A Iacobuzio-Donahue
    Cancer Discovery Jan 2020, CD-19-1508; DOI: 10.1158/2159-8290.CD-19-1508
  • Non-Coding Variants Connect Enhancer Dysregulation with Nuclear Receptor Signaling in Hematopoietic Malignancies
    Kailong Li, Yuannyu Zhang, Xin Liu, Yuxuan Liu, Zhimin Gu, Hui Cao, Kathryn E. Dickerson, Mingyi Chen, Weina Chen, Zhen Shao, Min Ni, Jian Xu
    Cancer Discovery Jan 2020, CD-19-1128; DOI: 10.1158/2159-8290.CD-19-1128
  • Global regulation of the histone mark H3K36me2 underlies epithelial plasticity and metastatic progression
    Salina Yuan, Ramakrishnan Natesan, Francisco J. Sanchez-Rivera, Jinyang Li, Natarajan V. Bhanu, Taiji Yamazoe, Jeffrey H. Lin, Allyson J. Merrell, Yogev Sela, Stacy K. Thomas, Yanqing Jiang, Jacqueline B. Plesset, Emma M. Miller, Junwei Shi, Benjamin A Garcia, Scott W. Lowe, Irfan A Asangani, Ben Z. Stanger
    Cancer Discovery Jan 2020, CD-19-1299; DOI: 10.1158/2159-8290.CD-19-1299
  • Mutations in the RNA splicing factor SF3B1 promote tumorigenesis through MYC stabilization
    Zhaoqi Liu, Akihide Yoshimi, Jiguang Wang, Hana Cho, Stanley Chun-Wei Lee, Michelle Ki, Lillian Bitner, Timothy Chu, Harshal Shah, Bo Liu, Anthony R. Mato, Peter Ruvolo, Giulia Fabbri, Laura Pasqualucci, Omar Abdel-Wahab, Raul Rabadan
    Cancer Discovery Jan 2020, CD-19-1330; DOI: 10.1158/2159-8290.CD-19-1330
  • Characteristics and Outcome of AKT1E17K-Mutant Breast Cancer Defined through AACR Project GENIE, a Clinicogenomic Registry
    Lillian M. Smyth, Qin Zhou, Bastien Nguyen, Celeste Yu, Eva M. Lepisto, Monica Arnedos, Michael J. Hasset, Michele L. Lenoue-Newton, Natalie Blauvelt, Semih Dogan, Christine M. Micheel, Chetna Wathoo, Hugo Horlings, Jan Hudecek, Benjamin E. Gross, Ritika Kundra, Shawn M. Sweeney, JianJiong Gao, Nikolaus Schultz, Andrew Zarski, Stuart M. Gardos, Jocelyn Lee, Seth Sheffler-Collins, Ben H. Park, Charles L. Sawyers, Fabrice André, Mia Levy, Funda Meric-Bernstam, Philippe L. Bedard, Alexia Iasonos, Deborah Schrag, David M. Hyman for the AACR Project GENIE Consortium
    Cancer Discovery Jan 2020, DOI: 10.1158/2159-8290.CD-19-1209

Pages